Cofactors of mortality among hospitalized HIV-infected children initiating antiretroviral therapy in Kenya
Journal of Acquired Immune Deficiency Syndromes May 23, 2019
Njuguna IN, et al. - Researchers sought for factors that could be associated with mortality among acutely ill HIV-infected children presenting with advanced HIV disease. In a randomized controlled trial, hospitalized, HIV-infected, antiretroviral therapy–naive children (0–12 years), initiated antiretroviral therapy were enrolled and were followed for 6 months. Observations revealed the independent predictive value of young age and orphaned or vulnerable child status for predicting mortality. Clinical features that predict mortality comprised hypoxic pneumonia, oral thrush, and persistent diarrhea. Findings emphasize the necessity for strategies that may enhance early diagnosis in children and may improve hospital management of critically ill HIV-infected children.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries